Insulin degludec

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Alternative Names: Tresiba

Tresiba (insulin degludec) is an ultra-long-acting basal insulin used to manage blood sugar in people with type 1 and type 2 diabetes. It provides a steady release of insulin for over 42 hours, allowing for flexible once-daily dosing at different times of day without losing effectiveness. Tresiba starts working within 1–2 hours and has no significant peak, which helps lower the risk of hypoglycemia. It is often used alongside rapid-acting insulin or other diabetes medications. Tresiba is available in prefilled pens and comes in multiple strengths, including U-100 and U-200.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

0

0 Reviews

Preferred by 0 Reviewers

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

1 = Very Expensive 5 = Very Affordable

0

Very Expensive

Relief Speed

1 = No Relief 5 = Immediate Relief

0

No Relief

Side Effects

1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect

Treatment Line

1 = Third-line or more 5 = First-line

0

Third-line or more

Choose treatments from the menu above to see how they compare side by side.

0

0 Reviews

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

No reviews yet.

Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.